Autoimmune diseases such as ulcerative colitis (UC) and myasthenia gravis
It was Blalock3 who had first performed thymectomy on a patient with MG in 1939. In the early decades of thymectomy for MG, myasthenic crisis caused serious states of respiratory arrest and many patients died of it just after the operation. In our group, in order to avoid consequent respiratory arrest after thymectomy, a method of suprasternal incision for thymectomy has been developed by Professor H. Yoshi matsu4,5 taking hints from the procedures of mediastinoscopy and pneumomediastinogra phy.6 Whole thymus is pulled out and removed quite anatomically and safely through a suprasternal incision. It is also possible to take biopsy specimens from thyroid, muscle or lymph nodes in this procedure. The first thymectomy case via the suprasternal notch performed by us was a 18-year-old girl with MG in 1964. 
Pneumomediastinography
One of the striking properties of normal thymus is the age involution. Around the age of 40, most of the thymus tissue is replaced by fat tissue.14,15 In the thymus of patients with MG or UC, however, such involution has not been observed. Pneumo mediastinography (PMG) was used to detect such persistent thymus.cas The instru ments for PMG are readily available at any medical institution (Fig. 1) . A needle with a slight curving at the tip was inserted between the lower pole of thyroid and the upper end of the sternum and proceeded along the posterior surface of the sternum. 200-250 ml of oxygen sterilized via a flask containing distilled water is then slowly injected into the anterior mediastinum. The figure of the thymus with a density similar to that of the heart is clearly revealed when lateral tomographies are taken (Fig. 2) . Thymectomy was also performed in 78 patients with UC (Table 1 ). The therapeutic effects of thymectomy was evaluated as either "unchanged" or "improved" in patients with MG. According to the follow-up study for more than 5 years during the approxi mately 20 year period between 1964 and 1985, improvement has been achieved in 60% of MG patients with thymoma, whereas improvement was noted in as many as 90% of MG patients with hyperplastic thymus (Fig. 3 ).
The effects of thymectomy in patients wtih UC were also examined. When percent remission was calculated by "patient-month" method in patients with UC, the percent remission was 78% on the conventional treatment alone. However, in patients in whom it was difficult to achieve complete cure by conventional treatment alone, percent re mission was only 60.6% before thymectomy. Even in such refractory patients, percent remission reached to 87.1% by thymectomy (Fig. 4 ). Since there was no tendency in the non-specific immune system, our attention was focussed on specific immune system. When some lymphocytes sensitized by a specific antigen are stimulated by the same antigen, these lymphocytes release a humoral factor called lymphocyte migration inhibition factor (LMIF), which inhibits the in vitro migra tion of white blood cells. The antibody titer in sera of the patients prior to thymectomy
is shown with open columns. The antibody titers after thymectomy are shown with two columns marked "Tx" . The titer in patients with hyperplastic thymus is de picted as "H", and the titer in patients with thymoma is de picted as "T". "X-ray"
indicates the cases treated with cobalt irradiation.
In MG, anti-acetylcholine receptor antibody (AChR-Ab) has been noted as one of the pathogenetic factors of the disease since 1970. Pirskanen in Sweden collaborated with us in early 70's compared AChR-Ab titer in sera of patients with MG among Japan, Sweden and Finland.28 In patients with hyperplastic thymus, AChR-Ab titer decreased after thymectomy. On the contrary, antibody titer in patients with thymoma increased after thymectomy but clinical symptoms were mostly improved. In patients sub jected to cobalt irradiation, the decrease of the titer was most pronounced (Fig. 6) . It would indicate that AChR-Ab titer did not correlate with clinical symptoms. It is suggested that the antibody titer did not decrease after thymectomy in the patients with thymoma, because only tumorous portion of thymus was removed and that non-tumorous portion of thymus remained to play an important role in the production of the antibody. In case of irradiation therapy, non-tumorous portion was also destroyed and then the antibody titer decreased. These data lead us to conclude that hyperplastic non-tumorous portion of the thymus is most important in the pathogenesis of this disease. One of other characteristic abnormalities in the thymus is the formation of lymph oid follicles which was seen in 80% of patients with MG and 40% of patients with UC.34 It was indicated that lymphoid follicle formation represented the focus of B cell proliferation in response to some antigenic stimulation and this formation in the thymus is frequently found out in patients with autoimmune diseases. Even if lymphoid follicle was not found out, it was demonstrated that some B cells were present in the area of cortico-medullary junction of the thymus, which was revealed by immunohistochem istry using an OKB1 monoclonal antibody.35 From the culture supernatant of KK-1, the fraction of virus was collected. Then this fraction was used as the antigen of the virus and serum of the patient with UC or MG was examined for the reactivity with this antigen by enzyme-linked immunosorbent assay (ELISA). It was revealed that there were antibodies to react with this virus in the sera of patients with UC and MG37 (Fig. 8) . Recently, molecular biological studies of this virus are being achieved.
Supernatant of thymus epithelial cell culture (STEC)
In order to test the release of some humoral factor from the thymus epithelium of the patients, the surgically removed thymus was minced and cultured in the medium supplemented with 20% fetal calf serum. Thymic epithelial cells gradually proliferated in monolayer after 1-2 weeks. We collected this culture supernatant (supernatant of thymus epithelial cell culture (STEC)) and various properties of this supernatant were studied.38,39
Humoral substances such as thymosin,40 thymin,41 thymic humoral factor (THF),42 and facteur thymique serique (FTS)43 secreted by the thymus have been so far studied (Fig. 9 ). STEC stimulated a specific antibody pro duction in vitro but did not stimulate non-specific antibody production. For example, STEC from the patients with MG (MG-STEC) increased in vitro production of AChR
Ab assayed using the procedure developed by Dr. Kobayashi at Kitasato Institute, but not of total IgG amount (Fig. 10) .
The biological functions of MG-STEC was compared with those of thymosin frac tion 5, FTS and STEC from patients with UC (UC-STEC). While MG-STEC as well as thymosin fraction 5 has a property of differentiating multipotential stem cells into E rosette forming cells, UC-STEC does not possess such a propertyy5 (Fig. 11) is postulated that this property is related to the maturation and differentiation of T cells.
The difference between MG-STEC and UC-STEC was further made clear by intra venous injection into mice. MG-STEC facilitated the differentiation of mouse thymo cytes while UC-STEC did not.46
The serum factors from patients with MG and UC (Thymus growth factor)
As thymic epithelial cells excrete some kinds of humoral factors, it was demon strated that some humoral factors related to the thymus was in the serum of the patient with MG or UC. Intravenous injection of sera from patients with MG or UC into C57BL/6 mice increased the mouse thymus in weight47 (Fig. 12) . The serum factor which had this activity was revealed to be a glycoprotein with a molecular weight of 14,800. Especially the serum factors of patients with UC induced the proliferation of the thymic epithelial cells that had been demonstrated by immunohistochemical method using an anti-keratin antibody.48 It was also demonstrated that this serum factors de creased Lyt-2-positive cell population, and increased L3T4-positive cell population by In vitro organ culture of normal mouse thymus was utilized to test the function of serum factors. The encapsulated fetal thymus was removed from a pregnant mouse under a stereoscopic microscope using microscalpel. Fetal thymus was then subjected to organ culture on a specific filter with addition of the patients' sera. The serum factors from patients with UC were found to increase the number of thymocytes in in vitro organ cultured thymus. Those from patients with MG did not have such a
property.
Prospective views for autoimmune diseases
Various immunological differences were found between MG and UC. As to HLA, specific patterns were noted in both diseases, suggesting a genetic background.50,51 In a general outline, thymic abnormalities appear to play a major rose in MG, whereas peripheral blood abnormalities were mainly responsible in UC. The abnormalities in peripheral T lymphocyte subsets are noted in UC, especially with a remarkable decrease in Leu2a positive cells. Serum factors from both diseases increased weight and cell number of mouse thymus in vivo, but in vitro, this property was found only in sera of patients with UC. In addition, various kinds of autoantibodies, such as AChR-Ab, Fig. 12 The effect of intravenous injection of sera from patients with myasthenia gravis and from those with ulcerative colitis in C57BL/6 mice. The weight of thymus was meas ured after the injection. After the administration of sera from the patients with myas thenia gravis, the weight of thymus increased 2 days after and decreased 4 days after, but re-increased.
When sera from the patients with ulcera tive colitis was injected, the weight of thymus was in creased gradually and reached the peak weight after 9 days. The effect of these injection of sera were different from each other. Clinically, thymoma is not found in patients with UC, but in patients with MG. This fact may be related to such abnormalities of the thymocyte themselves in MG (Table 2) .
Lastly, thymic abnormalities and immunoregulatory therapy in MG and UC will be discussed. MG is thought to be caused by thymic abnormalities induced by infec from thymic epithelial cells, causing lymphocyte abnormality. Thymic blood barrier may be destroyed by some unknown causes and B cells entering from the peripheral blood stream may form lymphoid follicles. AChR expressed on myoid cells may be recognized in the thymus and autoantibodies may be produced. AChR is recognized as non-self by lymphocytes and then sensitized T cells are produced. Abnormal T and B-cells distributed in the periphery enhanced the production of AChR-Ab which dam aged the neuromusclar junction. Adequate combination therapy as shown in Fig. 13 , should be performed. 
